BlackRock Institutional Trust Company, N.A. - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 151 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$15,381,000
+48.0%
459,134
+17.5%
0.00%0.0%
Q3 2016$10,396,000
+25.3%
390,688
+3.8%
0.00%
+100.0%
Q2 2016$8,296,000
-24.5%
376,248
+0.5%
0.00%
-50.0%
Q1 2016$10,990,000
-11.1%
374,196
-0.0%
0.00%0.0%
Q4 2015$12,360,000
-13.5%
374,316
-5.4%
0.00%0.0%
Q3 2015$14,296,000
-10.5%
395,583
+11.5%
0.00%
-33.3%
Q2 2015$15,967,000
+60.6%
354,891
+9.3%
0.00%
+50.0%
Q1 2015$9,941,000
+15.8%
324,645
+92.3%
0.00%
+100.0%
Q4 2014$8,586,000
+42.2%
168,859
+10.7%
0.00%0.0%
Q3 2014$6,036,000
+20.6%
152,550
+31.3%
0.00%0.0%
Q2 2014$5,003,000
+210.7%
116,164
+188.6%
0.00%
Q1 2014$1,610,000
+11.3%
40,249
-24.0%
0.00%
Q4 2013$1,446,000
-23.0%
52,991
-35.3%
0.00%
Q3 2013$1,878,000
-42.3%
81,926
-55.4%
0.00%
-100.0%
Q2 2013$3,252,000183,6330.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 862,848$42,556,00014.73%
Fairmount Funds Management LLC 171,147$8,441,0003.56%
ARMISTICE CAPITAL, LLC 1,648,000$81,279,0001.87%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$98,393,0000.49%
Jackson Creek Investment Advisors LLC 21,409$1,056,0000.37%
Hennion & Walsh Asset Management, Inc. 113,940$5,620,0000.34%
Virtus ETF Advisers LLC 14,721$726,0000.31%
Granahan Investment Management 193,416$9,539,0000.20%
Yorktown Management & Research Co Inc 4,500$222,0000.18%
JACOBS LEVY EQUITY MANAGEMENT, INC 242,257$11,948,0000.09%
View complete list of ENANTA PHARMACEUTICALS INC shareholders